首页 > 最新文献

Annals of Internal Medicine最新文献

英文 中文
The Misplaced Push to Restrict Access to Gabapentin. 错误地推动限制加巴喷丁的使用。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.7326/ANNALS-24-00940
Geoff Hollett, Karen Dionesotes, Joshua M Cohen, Noel Deep, Jennie B Jarrett
{"title":"The Misplaced Push to Restrict Access to Gabapentin.","authors":"Geoff Hollett, Karen Dionesotes, Joshua M Cohen, Noel Deep, Jennie B Jarrett","doi":"10.7326/ANNALS-24-00940","DOIUrl":"https://doi.org/10.7326/ANNALS-24-00940","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142339566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In persistent uncontrolled asthma, adding azithromycin to standard therapy increased clinical remission rates at 1 y. 对于持续不受控制的哮喘患者,在标准疗法中加入阿奇霉素可提高1年后的临床缓解率。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.7326/ANNALS-24-02230-JC
Christine F McDonald

Source citation: Thomas D, McDonald VM, Stevens S, et al. Effect of azithromycin on asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomized, double-anonymized, placebo-controlled trial. Chest. 2024;166:262-270. 38431051.

来源引用:Thomas D、McDonald VM、Stevens S 等:阿奇霉素对哮喘持续失控成人患者哮喘缓解的影响:随机、双匿名、安慰剂对照试验的二次分析。Chest.2024;166:262-270.38431051.
{"title":"In persistent uncontrolled asthma, adding azithromycin to standard therapy increased clinical remission rates at 1 y.","authors":"Christine F McDonald","doi":"10.7326/ANNALS-24-02230-JC","DOIUrl":"10.7326/ANNALS-24-02230-JC","url":null,"abstract":"<p><strong>Source citation: </strong>Thomas D, McDonald VM, Stevens S, et al. <b>Effect of azithromycin on asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomized, double-anonymized, placebo-controlled trial.</b> Chest. 2024;166:262-270. 38431051.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142339560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Web Exclusive. Annals Graphic Medicine - Imposter. 图形医学年鉴》--冒名顶替。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 Epub Date: 2024-09-24 DOI: 10.7326/G23-0058
Rachel Weber
{"title":"Web Exclusive. Annals Graphic Medicine - Imposter.","authors":"Rachel Weber","doi":"10.7326/G23-0058","DOIUrl":"10.7326/G23-0058","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142306974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abortion. 堕胎。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 Epub Date: 2024-10-08 DOI: 10.7326/ANNALS-24-01868
Cynthia H Chuang, Sarah Horvath

Induced abortion is safe, is common, and reduces pregnancy-related maternal morbidity and mortality. Internal medicine physicians are uniquely positioned to counsel patients on their pregnancy options, assess medical risks of pregnancy in the context of comorbidities, refer for abortion care when the patient desires it, or provide abortion care themselves. Clinicians can also provide anticipatory guidance about what patients should expect if they seek abortion care.

人工流产安全、常见,并能降低与妊娠相关的孕产妇发病率和死亡率。内科医生在以下方面具有独特的优势:为患者提供有关妊娠选择的咨询、根据合并症评估妊娠的医疗风险、在患者希望时转诊人工流产护理或亲自提供人工流产护理。临床医生还可以就患者寻求人工流产护理时的预期提供预期指导。
{"title":"Abortion.","authors":"Cynthia H Chuang, Sarah Horvath","doi":"10.7326/ANNALS-24-01868","DOIUrl":"10.7326/ANNALS-24-01868","url":null,"abstract":"<p><p>Induced abortion is safe, is common, and reduces pregnancy-related maternal morbidity and mortality. Internal medicine physicians are uniquely positioned to counsel patients on their pregnancy options, assess medical risks of pregnancy in the context of comorbidities, refer for abortion care when the patient desires it, or provide abortion care themselves. Clinicians can also provide anticipatory guidance about what patients should expect if they seek abortion care.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In adults with metabolic dysfunction, the MAF-5 score predicted risk for liver fibrosis (AUC range, 0.73 to 0.81). 在代谢功能障碍的成人中,MAF-5 评分可预测肝纤维化的风险(AUC 范围为 0.73 至 0.81)。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.7326/ANNALS-24-02090-JC
Jacob Korula

Source citation: van Kleef LA, Francque SM, Prieto-Ortiz JE, et al. Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction. Gastroenterology. 2024;167:357-367.e9. 38513745.

资料来源:van Kleef LA、Francque SM、Prieto-Ortiz JE 等。 代谢功能障碍相关纤维化 5(MAF-5)评分可预测代谢功能障碍普通人群的肝纤维化风险和结局。胃肠病学》。2024;167:357-367.e9.38513745.
{"title":"In adults with metabolic dysfunction, the MAF-5 score predicted risk for liver fibrosis (AUC range, 0.73 to 0.81).","authors":"Jacob Korula","doi":"10.7326/ANNALS-24-02090-JC","DOIUrl":"10.7326/ANNALS-24-02090-JC","url":null,"abstract":"<p><strong>Source citation: </strong>van Kleef LA, Francque SM, Prieto-Ortiz JE, et al. <b>Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction.</b> Gastroenterology. 2024;167:357-367.e9. 38513745.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142339554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In adults with moderate-to-severe OSA and obesity, tirzepatide reduced apnea-hypopnea events vs. placebo. 对于患有中重度 OSA 和肥胖症的成人,与安慰剂相比,替扎帕肽可减少呼吸暂停-低通气事件。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.7326/ANNALS-24-02174-JC
Lawrence J Cheskin, Selvi Rajagopal

Source citation: Malhotra A, Grunstein RR, Fietze I, et al; SURMOUNT-OSA Investigators. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 21 Jun 2024. [Epub ahead of print.] 38912654.

来源引用:Malhotra A, Grunstein RR, Fietze I, et al; SURMOUNT-OSA Investigators.用于治疗阻塞性睡眠呼吸暂停和肥胖症的 Tirzepatide。N Engl J Med.21 Jun 2024.[Epub ahead of print.] 38912654.
{"title":"In adults with moderate-to-severe OSA and obesity, tirzepatide reduced apnea-hypopnea events vs. placebo.","authors":"Lawrence J Cheskin, Selvi Rajagopal","doi":"10.7326/ANNALS-24-02174-JC","DOIUrl":"10.7326/ANNALS-24-02174-JC","url":null,"abstract":"<p><strong>Source citation: </strong>Malhotra A, Grunstein RR, Fietze I, et al; SURMOUNT-OSA Investigators. <b>Tirzepatide for the treatment of obstructive sleep apnea and obesity.</b> N Engl J Med. 21 Jun 2024. [Epub ahead of print.] 38912654.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142339555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Would You Manage This Patient With Obesity? Grand Rounds Discussion From Beth Israel Deaconess Medical Center. 您如何管理这位肥胖症患者?贝斯以色列女执事医疗中心大讲堂讨论。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 Epub Date: 2024-10-08 DOI: 10.7326/ANNALS-24-01740
Risa B Burns, Melanie R Jay, Anne N Thorndike, Zahir Kanjee

In 2022, 1 in 8 people in the world were living with obesity, and lifestyle interventions that include diet, exercise, and behavioral modification have been the foundation for management of obesity. Recently, pharmacologic therapies have been developed for management of obesity, the newest of these being glucagon-like peptide 1 receptor agonists. With the development of new pharmacologic options, the American Gastroenterological Association developed a guideline in 2022 to provide evidence-based recommendations for the pharmacologic management of obesity in adults and recommended, for adults with obesity or overweight with weight-related complications who have had an inadequate response to lifestyle interventions, adding pharmacologic agents to lifestyle interventions over continuing lifestyle interventions alone. In this article, 2 experts review the available evidence to answer the following questions: How effective are lifestyle interventions for the treatment of obesity? How effective are pharmacologic interventions for the treatment of obesity? Given these options, how do you engage in a shared decision-making discussion to develop a mutually agreed-on treatment plan?

2022 年,全球每 8 人中就有 1 人患有肥胖症,而包括饮食、运动和行为调整在内的生活方式干预一直是控制肥胖症的基础。最近,针对肥胖症的药物疗法也得到了发展,其中最新的疗法是胰高血糖素样肽 1 受体激动剂。随着新药理疗法的发展,美国胃肠病学协会于 2022 年制定了一份指南,为成人肥胖症的药理治疗提供循证建议,并建议对生活方式干预效果不佳、患有肥胖症或超重并伴有体重相关并发症的成人,在生活方式干预的基础上增加药理疗法,而不是继续单纯的生活方式干预。在本文中,两位专家回顾了现有证据,以回答以下问题:生活方式干预治疗肥胖症的效果如何?药物干预治疗肥胖症的效果如何?在有这些选择的情况下,如何进行共同决策讨论,以制定双方都同意的治疗方案?
{"title":"How Would You Manage This Patient With Obesity? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.","authors":"Risa B Burns, Melanie R Jay, Anne N Thorndike, Zahir Kanjee","doi":"10.7326/ANNALS-24-01740","DOIUrl":"10.7326/ANNALS-24-01740","url":null,"abstract":"<p><p>In 2022, 1 in 8 people in the world were living with obesity, and lifestyle interventions that include diet, exercise, and behavioral modification have been the foundation for management of obesity. Recently, pharmacologic therapies have been developed for management of obesity, the newest of these being glucagon-like peptide 1 receptor agonists. With the development of new pharmacologic options, the American Gastroenterological Association developed a guideline in 2022 to provide evidence-based recommendations for the pharmacologic management of obesity in adults and recommended, for adults with obesity or overweight with weight-related complications who have had an inadequate response to lifestyle interventions, adding pharmacologic agents to lifestyle interventions over continuing lifestyle interventions alone. In this article, 2 experts review the available evidence to answer the following questions: How effective are lifestyle interventions for the treatment of obesity? How effective are pharmacologic interventions for the treatment of obesity? Given these options, how do you engage in a shared decision-making discussion to develop a mutually agreed-on treatment plan?</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Ultrasound-Guided Rendezvous Technique Versus Precut Sphincterotomy as Salvage Technique in Patients With Benign Biliary Disease and Difficult Biliary Cannulation : A Randomized Controlled Trial. 在良性胆道疾病和胆道插管困难的患者中,将内镜超声引导会师技术与预切括约肌切开术作为挽救技术:一项随机对照试验。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 Epub Date: 2024-08-27 DOI: 10.7326/M24-0092
Arup Choudhury, Jayanta Samanta, Gaurav Muktesh, Jahnvi Dhar, Antriksh Kumar, Jimil Shah, Marco Spadaccini, Pankaj Gupta, Alessandro Fugazza, Vikas Gupta, Thakur Deen Yadav, Rakesh Kochhar, Cesare Hassan, Alessandro Repici, Antonio Facciorusso

Background: The standard salvage technique used for difficult bile duct cannulation is precut sphincterotomy, whereas endoscopic ultrasound-guided rendezvous technique (EUS-RV) is a relatively newer method. Prospective comparative data between these 2 techniques as salvage for biliary access in patients with benign biliary disease and difficult bile duct cannulation is lacking.

Objective: To compare EUS-RV and precut sphincterotomy as salvage technique for difficult bile duct cannulation in benign biliary obstruction.

Design: Participant-masked, parallel-group, superiority, randomized controlled trial. (Clinical Trials Registry of India: CTRI/2020/07/026613).

Setting: Tertiary care academic institute from July 2020 to May 2021.

Participants: All patients with benign biliary disease and difficult bile duct cannulation requiring salvage strategy.

Intervention: Patients were randomly assigned by computer-generated randomized blocks sequence in 1:1 fashion to either EUS-RV or precut sphincterotomy. Patients with failure in EUS-RV were crossed over to precut sphincterotomy and vice versa.

Measurements: The primary outcome measure was technical success. The other outcome measures included procedure time, radiation dose, and adverse events.

Results: In total, 100 patients were randomly assigned to EUS-RV (n = 50) and precut sphincterotomy (n = 50). The technical success rate (92% vs. 90%; P = 1.00; relative risk, 1.02 [95% CI, 0.90 to 1.16]), median procedure time (10.1 vs. 9.75 minutes), and overall complication rate (12% vs. 10%; relative risk, 1.20 [CI, 0.39 to 3.68]) were similar between the 2 groups. Five patients (10%) in the EUS-RV group and 5 patients (10%) in the precut sphincterotomy group had developed post-endoscopic retrograde cholangiopancreatography pancreatitis. All failed cases in either salvage group could be successfully cannulated when crossed over to the other group.

Limitation: Single center study done by experts.

Conclusion: Endoscopic ultrasound-guided rendezvous technique and precut sphincterotomy have similar success rates as salvage techniques in the technically challenging cohort of difficult bile duct cannulation for benign biliary disease, with acceptable complications rates.

Primary funding source: None.

背景:用于困难胆管插管的标准抢救技术是预切括约肌切开术,而内镜超声引导会合技术(EUS-RV)是一种相对较新的方法。这两种技术作为良性胆道疾病和胆管插管困难患者胆道通路的挽救方法,目前还缺乏前瞻性的比较数据:比较 EUS-RV 和预切括约肌切开术作为良性胆道梗阻胆管插管困难时的挽救技术:设计:参与者掩蔽、平行组、优越性随机对照试验。(印度临床试验注册中心:CTRI/2020/07/026613):2020年7月至2021年5月,三级医疗学术机构:所有良性胆道疾病和胆管插管困难且需要挽救策略的患者:患者通过计算机生成的随机区组序列以 1:1 的方式随机分配到 EUS-RV 或预切开括约肌切开术。EUS-RV 失败的患者被交叉分配到预切括约肌切开术,反之亦然:主要结果指标为技术成功率。其他结果指标包括手术时间、辐射剂量和不良事件:共有 100 名患者被随机分配到 EUS-RV(50 人)和括约肌切开术(50 人)。两组的技术成功率(92% 对 90%;P = 1.00;相对风险为 1.02 [95% CI,0.90 至 1.16])、中位手术时间(10.1 分钟对 9.75 分钟)和总体并发症发生率(12% 对 10%;相对风险为 1.20 [CI,0.39 至 3.68])相似。EUS-RV 组和预切开括约肌组分别有 5 名患者(10%)在内镜逆行胰胆管造影术后出现胰腺炎。所有抢救组的失败病例在转入另一组时都能成功插管:局限性:由专家进行的单中心研究:结论:内镜超声引导下会合技术和预切括约肌切开术作为良性胆道疾病胆管困难插管技术中的挽救技术,成功率相似,并发症发生率可接受:无。
{"title":"Endoscopic Ultrasound-Guided Rendezvous Technique Versus Precut Sphincterotomy as Salvage Technique in Patients With Benign Biliary Disease and Difficult Biliary Cannulation : A Randomized Controlled Trial.","authors":"Arup Choudhury, Jayanta Samanta, Gaurav Muktesh, Jahnvi Dhar, Antriksh Kumar, Jimil Shah, Marco Spadaccini, Pankaj Gupta, Alessandro Fugazza, Vikas Gupta, Thakur Deen Yadav, Rakesh Kochhar, Cesare Hassan, Alessandro Repici, Antonio Facciorusso","doi":"10.7326/M24-0092","DOIUrl":"10.7326/M24-0092","url":null,"abstract":"<p><strong>Background: </strong>The standard salvage technique used for difficult bile duct cannulation is precut sphincterotomy, whereas endoscopic ultrasound-guided rendezvous technique (EUS-RV) is a relatively newer method. Prospective comparative data between these 2 techniques as salvage for biliary access in patients with benign biliary disease and difficult bile duct cannulation is lacking.</p><p><strong>Objective: </strong>To compare EUS-RV and precut sphincterotomy as salvage technique for difficult bile duct cannulation in benign biliary obstruction.</p><p><strong>Design: </strong>Participant-masked, parallel-group, superiority, randomized controlled trial. (Clinical Trials Registry of India: CTRI/2020/07/026613).</p><p><strong>Setting: </strong>Tertiary care academic institute from July 2020 to May 2021.</p><p><strong>Participants: </strong>All patients with benign biliary disease and difficult bile duct cannulation requiring salvage strategy.</p><p><strong>Intervention: </strong>Patients were randomly assigned by computer-generated randomized blocks sequence in 1:1 fashion to either EUS-RV or precut sphincterotomy. Patients with failure in EUS-RV were crossed over to precut sphincterotomy and vice versa.</p><p><strong>Measurements: </strong>The primary outcome measure was technical success. The other outcome measures included procedure time, radiation dose, and adverse events.</p><p><strong>Results: </strong>In total, 100 patients were randomly assigned to EUS-RV (<i>n</i> = 50) and precut sphincterotomy (<i>n</i> = 50). The technical success rate (92% vs. 90%; <i>P</i> = 1.00; relative risk, 1.02 [95% CI, 0.90 to 1.16]), median procedure time (10.1 vs. 9.75 minutes), and overall complication rate (12% vs. 10%; relative risk, 1.20 [CI, 0.39 to 3.68]) were similar between the 2 groups. Five patients (10%) in the EUS-RV group and 5 patients (10%) in the precut sphincterotomy group had developed post-endoscopic retrograde cholangiopancreatography pancreatitis. All failed cases in either salvage group could be successfully cannulated when crossed over to the other group.</p><p><strong>Limitation: </strong>Single center study done by experts.</p><p><strong>Conclusion: </strong>Endoscopic ultrasound-guided rendezvous technique and precut sphincterotomy have similar success rates as salvage techniques in the technically challenging cohort of difficult bile duct cannulation for benign biliary disease, with acceptable complications rates.</p><p><strong>Primary funding source: </strong>None.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142071795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Effects of Individualized Acupuncture for Chronic Neck Pain : A Randomized Controlled Trial. 个性化针灸治疗慢性颈痛的长期效果:随机对照试验。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 Epub Date: 2024-09-03 DOI: 10.7326/M23-2425
Ling Zhao, Mingsheng Sun, Zihan Yin, Jin Cui, Ruihui Wang, Laixi Ji, Guoyan Geng, Jiao Chen, Dingjun Cai, Qi Liu, Hui Zheng, Fanrong Liang

Background: Long-term effects of individualized acupuncture in persons with chronic neck pain (CNP) remain unknown.

Objective: To evaluate the efficacy and safety of pressure pain, sensory-based individualized acupuncture for relieving CNP.

Design: A 24-week multicenter randomized controlled clinical trial. (ChiCTR1800016371).

Setting: Outpatient settings at 4 clinical centers in China from May 2018 to March 2020.

Participants: 716 participants with CNP.

Intervention: Participants were randomly assigned to a waiting list (WL) group or to 1 of 3 interventions, which consisted of 10 sessions over 4 weeks: higher sensitive acupoints (HSA), lower sensitive acupoints (LSA), and sham acupoints (SA) acupuncture groups.

Measurements: The primary outcome was the change in the visual analogue scale (VAS) score for neck pain (range, 0 to 100) from baseline to 4 weeks, with a difference of 10 points considered the minimum clinically important threshold. The VAS was also assessed every 4 weeks through 24 weeks.

Results: The modified intention-to-treat population included 683 participants. The mean baseline VAS was 50.36, 50.10, 49.24, and 49.16 for HSA, LSA, SA, and WL, respectively. Compared with a mean baseline to week 4 change of -12.16 in the HSA group, the mean changes were -10.19 in the LSA group (net difference [ND], -1.97 [95% CI, -5.03 to 1.09]), -6.11 in the SA group (ND, -6.05 [CI, -9.10 to -3.00]), and -2.24 in the WL group (ND, -9.93 [CI, -12.95 to -6.90]). The intervention effects persisted at 24-week follow-up.

Limitation: Lack of complete blinding and limited generalizability.

Conclusion: Individualized acupuncture interventions using high- or low-sensitivity acupuncture points were more effective in reducing CNP than SA and WL control groups sustained through 24 weeks, but the magnitude of relative improvement did not reach a minimal clinically important difference.

Primary funding source: National Natural Science Foundation of China.

背景:针灸对慢性颈部疼痛(CNP)患者的长期疗效尚不清楚:个体化针灸对慢性颈部疼痛(CNP)患者的长期效果仍然未知:评估基于压痛和感觉的个体化针灸对缓解慢性颈痛的疗效和安全性:设计:为期24周的多中心随机对照临床试验。(ChiCTR1800016371).Setting:2018年5月至2020年3月,中国4个临床中心的门诊环境.参与者:716名CNP参与者:716名CNP患者:参与者被随机分配至等待名单(WL)组或3个干预中的1个,干预包括4周内的10次治疗:较高敏感穴位组(HSA)、较低敏感穴位组(LSA)和假穴位组(SA):主要结果是颈部疼痛视觉模拟量表(VAS)评分(范围从 0 到 100)从基线到 4 周的变化,10 分的差异被认为是最小临床意义阈值。在24周内,每4周对VAS进行一次评估:修改后的意向治疗人群包括 683 名参与者。HSA、LSA、SA 和 WL 的平均基线 VAS 分别为 50.36、50.10、49.24 和 49.16。与 HSA 组从基线到第 4 周的平均变化-12.16 相比,LSA 组的平均变化为-10.19(净差值 [ND],-1.97 [95% CI,-5.03 到 1.09]),SA 组为-6.11(ND,-6.05 [CI,-9.10 到 -3.00]),WL 组为-2.24(ND,-9.93 [CI,-12.95 到 -6.90])。干预效果在24周的随访中持续存在:局限性:缺乏完全盲法,可推广性有限:结论:与SA和WL对照组相比,使用高敏或低敏穴位的个体化针灸干预能更有效地降低CNP,并持续24周,但相对改善的程度未达到最小临床重要差异:国家自然科学基金
{"title":"Long-Term Effects of Individualized Acupuncture for Chronic Neck Pain : A Randomized Controlled Trial.","authors":"Ling Zhao, Mingsheng Sun, Zihan Yin, Jin Cui, Ruihui Wang, Laixi Ji, Guoyan Geng, Jiao Chen, Dingjun Cai, Qi Liu, Hui Zheng, Fanrong Liang","doi":"10.7326/M23-2425","DOIUrl":"10.7326/M23-2425","url":null,"abstract":"<p><strong>Background: </strong>Long-term effects of individualized acupuncture in persons with chronic neck pain (CNP) remain unknown.</p><p><strong>Objective: </strong>To evaluate the efficacy and safety of pressure pain, sensory-based individualized acupuncture for relieving CNP.</p><p><strong>Design: </strong>A 24-week multicenter randomized controlled clinical trial. (ChiCTR1800016371).</p><p><strong>Setting: </strong>Outpatient settings at 4 clinical centers in China from May 2018 to March 2020.</p><p><strong>Participants: </strong>716 participants with CNP.</p><p><strong>Intervention: </strong>Participants were randomly assigned to a waiting list (WL) group or to 1 of 3 interventions, which consisted of 10 sessions over 4 weeks: higher sensitive acupoints (HSA), lower sensitive acupoints (LSA), and sham acupoints (SA) acupuncture groups.</p><p><strong>Measurements: </strong>The primary outcome was the change in the visual analogue scale (VAS) score for neck pain (range, 0 to 100) from baseline to 4 weeks, with a difference of 10 points considered the minimum clinically important threshold. The VAS was also assessed every 4 weeks through 24 weeks.</p><p><strong>Results: </strong>The modified intention-to-treat population included 683 participants. The mean baseline VAS was 50.36, 50.10, 49.24, and 49.16 for HSA, LSA, SA, and WL, respectively. Compared with a mean baseline to week 4 change of -12.16 in the HSA group, the mean changes were -10.19 in the LSA group (net difference [ND], -1.97 [95% CI, -5.03 to 1.09]), -6.11 in the SA group (ND, -6.05 [CI, -9.10 to -3.00]), and -2.24 in the WL group (ND, -9.93 [CI, -12.95 to -6.90]). The intervention effects persisted at 24-week follow-up.</p><p><strong>Limitation: </strong>Lack of complete blinding and limited generalizability.</p><p><strong>Conclusion: </strong>Individualized acupuncture interventions using high- or low-sensitivity acupuncture points were more effective in reducing CNP than SA and WL control groups sustained through 24 weeks, but the magnitude of relative improvement did not reach a minimal clinically important difference.</p><p><strong>Primary funding source: </strong>National Natural Science Foundation of China.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142118828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated With Recurrent Pediatric Firearm Injury : A 10-Year Retrospective Cohort Analysis. 小儿枪伤复发的相关因素:10 年回顾性队列分析。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 Epub Date: 2024-09-17 DOI: 10.7326/M24-0430
Zoe M Miller, Benjamin P Cooper, Daphne Lew, Rachel M Ancona, Vicki Moran, Christopher Behr, Marguerite W Spruce, Lindsay M Kranker, Michael A Mancini, Matt Vogel, Doug J E Schuerer, Lindsay Clukies, Megan L Ranney, Randi E Foraker, Kristen L Mueller

Background: Firearm injuries are the leading cause of death among children aged 0 to 17 years in the United States.

Objective: To examine the factors associated with recurrent firearm injury among children who presented with acute (index) nonfatal firearm injury in the St. Louis region.

Design: Multicenter, observational, cohort study.

Setting: 2 adult and 2 pediatric level I trauma hospitals in St. Louis, Missouri.

Participants: Pediatric patients aged 0 to 17 years presenting with an index firearm injury between 2010 and 2019.

Measurements: From the St. Louis Region-Wide Hospital-Based Violence Intervention Program Data Repository, we collected data on firearm-injured patient demographics, hospital and diagnostic information, health insurance status, and mortality. The Social Vulnerability Index was used to characterize the social vulnerability of the census tracts of patients' residences. Analysis included descriptive statistics and time-to-event analyses estimating the cumulative incidence of experiencing a recurrent firearm injury.

Results: During the 10-year study period, 1340 children presented with an index firearm injury. Most patients were Black (87%), non-Hispanic (99%), male (84%), and between the ages of 15 and 17 years (67%). The estimated risk for firearm reinjury was 6% at 1 year and 14% at 5 years after initial injury. Male children and those seen at an adult hospital were at increased risk for reinjury.

Limitation: Our data set does not account for injuries occurring outside of the study period and for reinjuries presenting to nonstudy hospitals.

Conclusion: Children who experience an initial firearm injury are at high risk for experiencing a recurrent firearm injury. Interventions are needed to reduce reinjury and address inequities in the demographic and clinical profiles within this cohort of children.

Primary funding source: National Institutes of Health.

背景:火器伤害是美国0至17岁儿童死亡的主要原因:目的:研究圣路易斯地区急性(指数)非致命性枪伤儿童中反复发生枪伤的相关因素:地点:密苏里州圣路易斯市的两家成人和两家儿科一级创伤医院:2010年至2019年期间,0至17岁的儿科患者因枪支受伤而发病:我们从圣路易斯地区医院暴力干预计划数据存储库中收集了枪伤患者的人口统计学、医院和诊断信息、医疗保险状况和死亡率等数据。社会脆弱性指数用于描述患者居住地人口普查区的社会脆弱性。分析包括描述性统计和时间到事件分析,以估计再次发生枪支伤害的累积发生率:在为期 10 年的研究期间,共有 1340 名儿童因枪支伤害而就诊。大多数患者为黑人(87%)、非西班牙裔(99%)、男性(84%),年龄在 15 至 17 岁之间(67%)。据估计,初次枪伤后 1 年和 5 年再次枪伤的风险分别为 6% 和 14%。男性儿童和在成人医院就诊的儿童再次受伤的风险更高:我们的数据集未考虑研究期间以外发生的伤害以及在非研究医院就诊的再次伤害:结论:初次遭受枪支伤害的儿童再次遭受枪支伤害的风险很高。需要采取干预措施来减少再次伤害,并解决这一儿童群体中人口和临床概况不平等的问题:主要资金来源:美国国立卫生研究院。
{"title":"Factors Associated With Recurrent Pediatric Firearm Injury : A 10-Year Retrospective Cohort Analysis.","authors":"Zoe M Miller, Benjamin P Cooper, Daphne Lew, Rachel M Ancona, Vicki Moran, Christopher Behr, Marguerite W Spruce, Lindsay M Kranker, Michael A Mancini, Matt Vogel, Doug J E Schuerer, Lindsay Clukies, Megan L Ranney, Randi E Foraker, Kristen L Mueller","doi":"10.7326/M24-0430","DOIUrl":"10.7326/M24-0430","url":null,"abstract":"<p><strong>Background: </strong>Firearm injuries are the leading cause of death among children aged 0 to 17 years in the United States.</p><p><strong>Objective: </strong>To examine the factors associated with recurrent firearm injury among children who presented with acute (index) nonfatal firearm injury in the St. Louis region.</p><p><strong>Design: </strong>Multicenter, observational, cohort study.</p><p><strong>Setting: </strong>2 adult and 2 pediatric level I trauma hospitals in St. Louis, Missouri.</p><p><strong>Participants: </strong>Pediatric patients aged 0 to 17 years presenting with an index firearm injury between 2010 and 2019.</p><p><strong>Measurements: </strong>From the St. Louis Region-Wide Hospital-Based Violence Intervention Program Data Repository, we collected data on firearm-injured patient demographics, hospital and diagnostic information, health insurance status, and mortality. The Social Vulnerability Index was used to characterize the social vulnerability of the census tracts of patients' residences. Analysis included descriptive statistics and time-to-event analyses estimating the cumulative incidence of experiencing a recurrent firearm injury.</p><p><strong>Results: </strong>During the 10-year study period, 1340 children presented with an index firearm injury. Most patients were Black (87%), non-Hispanic (99%), male (84%), and between the ages of 15 and 17 years (67%). The estimated risk for firearm reinjury was 6% at 1 year and 14% at 5 years after initial injury. Male children and those seen at an adult hospital were at increased risk for reinjury.</p><p><strong>Limitation: </strong>Our data set does not account for injuries occurring outside of the study period and for reinjuries presenting to nonstudy hospitals.</p><p><strong>Conclusion: </strong>Children who experience an initial firearm injury are at high risk for experiencing a recurrent firearm injury. Interventions are needed to reduce reinjury and address inequities in the demographic and clinical profiles within this cohort of children.</p><p><strong>Primary funding source: </strong>National Institutes of Health.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537306/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1